Exercise-induced 3′-sialyllactose in breast milk is a critical mediator to improve metabolic health and cardiac function in mouse offspring

Johan E., Harris, Kelsey M., Pinckard, Katherine R., Wright, Lisa A., Baer, Peter J., Arts, Eaman, Abay, Vikram K., Shettigar, Adam C., Lehnig, Bianca, Robertson, Kendra, Madaris, Tyler J., Canova, Clark, Sims, Laurie J., Goodyear, Aline, Andres, Mark T., Ziolo, Lars, Bode, Kristin I., Stanford

Nature Metabolism |

Poor maternal environments, such as under- or overnutrition, can increase the risk for the development of obesity, type 2 diabetes and cardiovascular disease in offspring1–9. Recent studies in animal models have shown that maternal exercise before and during pregnancy abolishes the age-related development of impaired glucose metabolism10–15, decreased cardiovascular function16 and increased adiposity11,15; however, the underlying mechanisms for maternal exercise to improve offspring’s health have not been identified. In the present study, we identify an exercise-induced increase in the oligosaccharide 3′-sialyllactose (3′-SL) in milk in humans and mice, and show that the beneficial effects of maternal exercise on mouse offspring’s metabolic health and cardiac function are mediated by 3′-SL. In global 3′-SL knockout mice (3′-SL−/−), maternal exercise training failed to improve offspring metabolic health or cardiac function in mice. There was no beneficial effect of maternal exercise on wild-type offspring who consumed milk from exercise-trained 3′-SL−/− dams, whereas supplementing 3′-SL during lactation to wild-type mice improved metabolic health and cardiac function in offspring during adulthood. Importantly, supplementation of 3′-SL negated the detrimental effects of a high-fat diet on body composition and metabolism. The present study reveals a critical role for the oligosaccharide 3′-SL in milk to mediate the effects of maternal exercise on offspring’s health. 3′-SL supplementation is a potential therapeutic approach to combat the development of obesity, type 2 diabetes and cardiovascular disease.